Skip to main content

Want a detailed portfolio tracker?

OmniAb (OABI) P/E (2022 - 2026)

OmniAb (OABI) P/E from Nov 2, 2022 to Jul 21, 2026. The TTM OmniAb (OABI) P/E is -5.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of OmniAb (OABI)

YearP/EChange
2026-5.28+40.32%
2025-3.76-44.64%
2024-6.80-71.80%
2023-24.12+142.93%
2022-9.93N/A

Comparison OmniAb (OABI) P/E with competitors

OmniAb (OABI) P/E is -5.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.42%
FGENFibroGen Inc0.24-104.54%
CHRSCoherus Biosciences Inc0.85-116.06%
FBIOFortress Biotech Inc0.95-117.96%
ORMPOramed Pharmaceuticals Inc1.50-128.45%
AGENAgenus Inc3.01-156.97%
INVAInnoviva Inc3.15-159.70%
VXRTVaxart Inc3.55-167.19%
CRMDCorMedix Inc3.63-168.68%
CVACCureVac N.V.4.45-184.15%
GLPGGalapagos NV4.86-191.97%
SRPTSarepta Therapeutics Inc4.88-192.41%
ABEOAbeona Therapeutics Inc5.39-201.97%
ABUSArbutus Biopharma Corp5.60-205.91%
ZVRAZevra Therapeutics Inc5.89-211.43%
SPROSpero Therapeutics Inc6.23-217.89%
CGENCompugen Ltd6.31-219.51%
RIGLRigel Pharmaceuticals6.87-230.07%
SLXNSilexion Therapeutics Corp7.30-238.10%
OMEROmeros Corporation9.26-275.25%
AUPHAurinia Pharmaceuticals Inc9.58-281.42%
PLXProtalix BioTherapeutics Inc10.89-306.14%
ACADAcadia Pharmaceuticals Inc11.73-322.00%
TBPHTheravance Biopharma Inc12.26-332.10%
ADMAAdma Biologics Inc12.42-335.05%
HRMYHarmony Biosciences Holdings Inc13.82-361.59%
SABSSAB Biotherapeutics Inc14.14-367.57%
NAGENiagen Bioscience Inc14.82-380.48%
INCYIncyte Corp15.82-399.49%
REGNRegeneron Pharmaceuticals Inc15.86-400.14%
PBYIPuma Biotechnology Inc17.32-427.75%
CPRXCatalyst Pharmaceuticals Inc17.44-430.09%
EXELExelixis Inc17.54-431.96%
TGTXTG Therapeutics Inc18.97-458.99%
MDXGMimedx Group Inc20.55-489.02%
XOMAXOMA Royalty Corp22.87-532.98%
ARGXArgen X SE24.30-559.93%
CTMXCytomX Therapeutics Inc24.82-569.83%
XOMAOXOMA Royalty Corp25.34-579.74%
HALOHalozyme Therapeutics Inc25.62-585.02%
XOMAPXOMA Royalty Corp25.67-585.90%
VRTXVertex Pharmaceuticals Inc27.99-629.90%
RPRXRoyalty Pharma plc - Class A28.69-643.01%
SLNOSoleno Therapeutics Inc29.02-649.22%
ASNDAscendis Pharma A/S30.09-669.48%
LGNDLigand Pharmaceuticals Inc - Class B37.91-817.62%
APLSApellis Pharmaceuticals Inc39.02-838.61%
BMRNBiomarin Pharmaceutical Inc42.21-899.01%
KRYSKrystal Biotech Inc45.34-958.29%
ONCBeiGene Ltd69.54-1416.30%
PHARPharming Group N.V.75.03-1520.13%
TECHBio-Techne Corp101.96-2029.92%
VCELVericel Corp109.92-2180.65%
ALNYAlnylam Pharmaceuticals Inc117.96-2332.91%
GMABGenmab140.29-2755.50%
TLXTelix Pharmaceuticals Ltd162.15-3169.32%
CORTCorcept Therapeutics Inc212.86-4129.09%